Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Nov 29, 2021 6:12pm

353 Views

Post# 34177784

Vera quote from the newsletter Nov

The data accrued to date for the
TLD 1433-2 open label study for the
treatment of NMIBC, seems very
encouraging, and Theralase may as
well be heading towards fulfilling the
necessary outcome requirements to
apply for a “BTD from the FDA very
soon

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China